Congressional Research Service Reports - 15 Matching Results

Search Results

prev Results: 11 - 15
open access

An Examination of the Issues Surrounding Biotechnology Patenting and Its Effect Upon Entrepreneurial Companies

Description: The biotechnology industry is notable both for its heavy concentration of small businesses and its weighty research and development (R&D) expenditures. Given the small size and heavy expenses of many biotechnology firms, their ability to raise venture capital may be of some consequence. The patent law has been identified as a facilitator of these R&D financing efforts. Congress may choose to exercise oversight on these issues. Such consideration would likely include examination of U.S. commitme… more
Date: August 31, 2000
Creator: Thomas, John R.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Patent Ownership and Federal Research and Development (R and D): A Discussion on the Bayh-Dole Act and the Stevenson-Wydler Act

Description: Two major laws govern the dispensation of patents associated with federal research and development (R&D) activities. Both P.L. 96-418, the Stevenson-Wydler Technology Innovation Act, as amended, and P.L. 96-517, Amendments to the Patent and Trademark Act (commonly referred to as "Bayh-Dole" after its two main sponsors, former Senators Birch Bayh and Robert Dole), are the foundation for efforts to utilize patent ownership to encourage the commercialization of technologies and techniques that hav… more
Date: December 11, 2000
Creator: Schacht, Wendy H.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an under… more
Date: June 19, 2000
Creator: Schacht, Wendy H.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
open access

The National Institutes of Health: An Overview

Description: The National Institutes of Health is the focal point of federal health research. It uses its $17.8 billion budget to support more than 50,000 scientists working at 2,000 institutions across the United States, as well as to conduct biomedical and behavioral research and research training at its own facilities.
Date: September 15, 2000
Creator: Smith, Pamela W.
Item Type: Refine your search to only Report
Partner: UNT Libraries Government Documents Department
Back to Top of Screen